HTHiroo Takayama

Hiroo Takayama

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hiroo Takayama has a total of 494 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Outcomes of Distal Aortic Reinterventions After Zone 2 Arch Replacement

    by Ali Fatehi Hassanabad, Samuel C. Russo, Alice Vinogradsky, Megan Chung, Yanling Zhao, Valeria Jimenez, Yuichiro Kitada, Paul Kurlansky, Thomas F. X. O’Donnell, Virendra Patel, et al.

    Background: Zone 2 aortic arch replacement (Z2R) is an effective strategy for treating aortic pathology. However, the frequency and consequences of distal reinterventions (DRs) remain unknown. We evaluated the outcomes associated with planned distal reinterventions (PDRs) and unplanned distal reinterventions (UDRs) after Z2R. Methods: Patients requiring PDRs or UDRs after Z2R between 2007 and 2024 were reviewed. CTA/MRA scans were analyzed for aortic remodeling. The primary outcome was a composite of postoperative mortality, dialysis, paralysis and stroke (thoracoabdominal aortic aneurysm life-altering event; TALE) after DR. Secondary outcomes included cumulative reintervention burden, progression of false lumen thrombosis, and survival. Results: Among 111 Z2R patients followed for a median of 3.5 (1.5, 6.6) years, 55 (49.5%) required a total of 82 DRs: 25 with ≥1 UDR and 30 with only PDRs. PDRs were more often endovascular (93% vs. 72%, p = 0.02). TALE rates were similar between PDRs and UDRs (PDR: 9.3% vs. UDR: 12.8%, p = 0.88). Patients with UDRs had a greater cumulative reintervention burden (MCF 3, 95% CI 2–5 vs. MCF 1, 95% CI 1–1; p = 0.005). Neither PDRs nor UDRs were associated with differences in risk-adjusted mortality compared with no DR. Among dissection patients, PDR (63%) and UDR (100%) were associated with greater progression of false lumen thrombosis in the distal descending aorta compared to no DR (47%) (p = 0.04). Conclusions: Distal reinterventions after Zone 2 arch replacement are common and represent an important component of longitudinal aortic management. Patients undergoing exclusively planned distal reinterventions demonstrated a lower observed cumulative procedural burden than patients who experienced unplanned interventions. However, differences in baseline pathology, treatment pathways, and selection bias limit causal interpretation. Larger studies are needed to determine whether deliberate staging improves long-term outcomes.

  • Exercise and Thoracic Aortic Aneurysms: A Paradigm Shift Toward Informed, Personalized Activity Guidelines

    by Habib Jabagi, Giuseppe Imperatore, Alex Nantsios, Louise Y. Sun, Alexandra Lewis, Munir Boodhwani, Hassan Mir, Hiroo Takayama, Himanshu Patel, Paul Burns, et al.

    Exercise is widely recognized for its cardiovascular benefits; however, its safety and role in patients with thoracic aortic aneurysms (TAAs) remains complex due to its distinctive biomechanical vulnerabilities. Fundamentally different from abdominal aortic aneurysms, TAAs develop from distinct pathophysiological processes that affect their hemodynamic responses to stressors and influence their risk of adverse aortic events. Exercise induces acute hemodynamic changes, including increased stroke volume, systolic and pulse pressures, and transient aortic stiffening. These changes impose mechanical stress on the aortic wall, potentially accelerating aneurysm progression or triggering adverse aortic events. Although moderate aerobic exercise generally appears safe with potential cardiovascular benefits, evidence supporting safe practices in TAAs is limited. Current guidelines frequently extrapolate from abdominal aortic aneurysm data, which overlook the specificities of the thoracic aorta. This review underscores the urgent need for comprehensive research, using advanced imaging, biomarker profiling, and real‐time hemodynamic monitoring to understand how different exercise modalities and intensities affect TAAs. Well‐designed prospective studies are crucial to improve risk stratification, optimize antihypertensive strategies, develop personalized exercise prescriptions, and provide evidence‐informed guidance to patients. Perioperative strategies like prehabilitation and structured postoperative rehabilitation show promise but lack rigorous evaluation. Ultimately, this work advocates a paradigm shift from conservative inactivity toward informed, individualized physical activity regimens tailored to each patient's risk profile. This approach aims to maximize cardiovascular benefits while minimizing adverse aortic events, thereby improving overall health and quality of life in patients with TAAs.

  • Comparison of Outcomes of Leadless Versus Transvenous Pacemakers Following Tricuspid Valve Surgery

    by Tomonari M. Shimoda, Yoshihisa Miyamoto, Hiroki A. Ueyama, Shinobu Itagaki, Tsuyoshi Kaneko, Hiroshi Gotanda, Kosuke Inoue, Shinichi Fukuhara, Gorav Ailawadi, Hiroo Takayama, et al.

    Background: Transvenous pacemaker implantation after tricuspid valve surgery may cause adverse outcomes due to lead–valve interactions. Although leadless pacemakers may mitigate these risks, empirical data remain limited. Methods: We compared outcomes of leadless versus transvenous pacemakers following tricuspid surgery using a target trial emulation framework. We analyzed Medicare beneficiaries aged ≥65 years who underwent tricuspid valve surgery and received a pacemaker during the index admission between 2017 and 2021, using propensity score matching weight analysis to control for confounders. Primary outcomes were in‐hospital death and 2‐year heart failure hospitalization. Secondary outcomes included 2‐year death. Results: We included 185 and 1336 patients in the leadless and transvenous groups, respectively. Use of leadless pacemakers increased from 6.3% in 2017 to 17.5% in 2021. Leadless pacemaker recipients more often underwent tricuspid valve replacement (29.2% versus 8.5%) while concomitant mitral surgery was less common (69.2% versus 86.8%). After adjustment, we found no evidence that in‐hospital death (adjusted odds ratio, 1.82 [95% CI, 0.65–5.13] for leadless) and 2‐year heart failure hospitalizations (subdistribution hazard ratio [HR], 0.88 [95% CI, 0.60–1.30] for leadless) differed between the 2 groups. We also found no evidence that 2‐year death (adjusted HR, 1.04 [95% CI, 0.69–1.57] for leadless) differed between groups. Conclusions: No statistically significant differences were detected between leadless versus transvenous pacemaker implantations after tricuspid valve surgery. However, CIs were wide, and a clinically meaningful difference in either direction cannot be excluded. The study may therefore be underpowered, and the absence of echocardiographic data limits assessment of tricuspid regurgitation, warranting prospective studies.

  • Open Access

    Hypoxemia after thoracic aortic aneurysm repair

    by Gift Owolabi, Yuichiro Kitada, Jack Nickles, Yanling Zhao, Paul Kurlansky, Lauren Sutherland, Jonathan Hastie, Thomas O'DOnnell, Virendra Patel, Adham Elmously, et al.

  • Open Access

    Narrative review of fluid dynamics in the left ventricle: from the perspective of aortic regurgitation

    by Yuichiro Kitada, Jack Nickles, Gift Owolabi, Jonathan Kochav, Muhammad Umair, Adham Elmously, Hideyuki Hayashi, Koichi Akiyama, Keiichi Itatani, Giovanni Ferrari, et al.

    Background and Objective: From a fluid dynamics perspective, understanding intraventricular blood flow is essential for clarifying the mechanisms, progression, and potential therapeutic targets of various cardiac diseases. Recent advancements in imaging techniques have enabled the visualization of left ventricle (LV) blood flow, particularly the vortex formed during diastole. However, the inherently complex and dynamic nature of LV fluid motion makes the quantitative assessment of vortex function highly challenging. The impact of aortic regurgitation (AR) on LV fluid dynamics is equally critical for understanding the progression of cardiac dysfunction, yet its exact influence remains largely unclear. This manuscript is a narrative review of this novel perspective of AR in the context of fluid dynamics. Methods: Articles from PubMed database and Google Scholar regarding LV blood flow and vortex assessment were reviewed. For the initial research, articles between 2010 and 2025 were prioritized, including original articles, case reports, and reviews. Following the initial search, additional articles were considered based on manual searches of references from the retrieved literature. Key Content and Findings: AR jets have several interactions with LV blood flow depending on its direction, and the eccentric jet can be oriented in several directions based on the relationship to the mitral inflow location. Conclusions: Various orientations of eccentric AR jet are possible and LV blood flow trajectory is modulated by the direction of AR jets. A reproducible classification of AR jet direction, combined with the quantification of vortex alterations according to jet direction, represents a vital step in elucidating the specific roles of these vortices in cardiac function.

  • Open Access

    Frozen elephant trunk: a narrative review of global and temporal trends

    by Jack Nickles, Megan Chung, Yuichiro Kitada, Marco Tagliafierro, Valeria Jimenez, Davide Pacini, George Arnaoutakis, Hiroo Takayama, Adham Elmously

    Background and Objective: The frozen elephant trunk (FET) repair has transitioned from a niche procedure to a widely adopted strategy across Asia, Europe, and North America. Multicenter registries demonstrate improving early outcomes over time, consistent with learning curve effects. Regional differences persist in case mix, device availability, and utilization. No study has systematically measured these regional differences. We aim to describe the history, evolution, and current landscape of FET worldwide. Methods: A narrative review of English-language adult studies from PubMed, Google Scholar and International Clinical Guidelines (January 2010–September 2025) was performed using procedural and device terminology. Multicenter registries and large single-center series reporting case volumes and outcomes (mortality, stroke, spinal cord ischemia) were included. Data on indication, regional techniques, device use, and clinical outcomes were extracted to identify global and temporal trends. Key Content and Findings: FET utilization demonstrates wide regional variability, further obscured by heterogeneity in published studies reporting either acute type A aortic dissection (ATAAD) specific or mixed pathology cohorts. China exhibits the highest utilization (48–78% of ATAAD patients). Japan has shown substantial growth over the past decade, with contemporary data indicating FET use in 20% of thoracic aortic cases. In contrast, United States utilization remains low (Conclusions: Global FET volume has risen markedly over two decades, driven by standardization of neuroprotective techniques and advanced hybrid prostheses. A core set of principles has emerged establishing FET as a safe and versatile option for complex aortic disease worldwide. However, differences in devices, patient populations, and procedural indications remain.

  • Open Access

    Free Versus In situ Right Internal Mammary Artery as a Conduit in Coronary Artery Bypass Surgery: A Meta-Analysis

    by Yuta Kikuchi, Tomoki Sakata, Tomonari Shimoda, Shinichi Fukuhara, Junichi Shimamura, Makoto Hibino, Tsuyoshi Kaneko, Hiroo Takayama, Hisato Takagi, Michel Pompeu Sa, et al.

    Objectives: There is debate regarding the optimal choice for a second conduit in coronary artery bypass grafting. The right internal mammary artery (RIMA) is commonly employed as a second conduit; however, it is unclear whether the free (fRIMA) or in situ (isRIMA) configuration yields superior outcomes. We performed a systematic review and meta-analysis to compare clinical outcomes between fRIMA and isRIMA as the second conduit. Methods: A comprehensive search of PubMed (MEDLINE), EMBASE, and CENTRAL was performed through May 2025 to identify studies comparing outcomes in patients undergoing coronary artery bypass grafting with either fRIMA or isRIMA as a second conduit. The outcomes of interest were overall mortality, graft occlusion, major adverse cardiac events (MACE), and repeat revascularization. Data with 95% confidence intervals (CIs) were extracted. Pooled analysis was performed using a random-effects model. Results: A total of 13 studies with 9899 patients were included (fRIMA, n = 3095; isRIMA, n = 6804). The median study follow-up duration ranged from 1 to 20 years across the studies. No statistically significant differences were observed in overall mortality (hazard ratio [95% CI] = 1.16 [0.79-1.69]), graft occlusion (1.04 [0.90-1.21]), MACE (0.87 [0.62-1.21]), and repeat revascularization (1.34 [0.68-2.66]). Conclusions: In this meta-analysis, no statistically significant differences were observed between fRIMA and isRIMA configurations across the evaluated clinical outcomes. These findings suggest that, within the limitations of available evidence, the choice between fRIMA and isRIMA may be guided by clinical context, surgeon preference, patient anatomy, and target vessel characteristics rather than expected differences in major clinical outcomes.


  • Open Access

    How to manage residual aortic regurgitation after an aortic valve-sparing operation: Practical tips

    by Gift Owolabi, Megan M. Chung, Jack Nickles, William J. MacDonald, Adham Elmously, Hiroo Takayama

  • Open Access

    Aortic root replacement after repaired congenital conotruncal defects: A surgical challenge

    by Megan M. Chung, Kavya Rajesh, Paridhi Agarwal, Elizabeth L. Norton, Alexander P. Nissen, Chris He, Yu Hohri, Andrew Goldstone, Edward P. Chen, Hiroo Takayama

  • EACTS Expert Consensus Document on protected cardiac surgery: pre-emptive use of temporary mechanical circulatory support in adult cardiac surgery patients at high risk for perioperative low cardiac output syndrome

    by Roberto Lorusso, Leonardo Salazar, Gaik Nersesian, Milan Milojevic, Bastian Schmack, Daniel T Engelman, Louis Stein, Scott Silvestry, Daniel Zimpfer, Dominik Wiedemann, et al.

    Perioperative low cardiac output syndrome (LCOS) remains a significant complication in adult cardiac surgery, contributing to substantial morbidity, prolonged intensive care, and increased mortality. Its incidence is expected to rise further due to the evolving complexity of referred surgical patients, often characterised by advanced age, multiple comorbidities, challenging anatomy, and impaired haemodynamics. Despite advances in pharmacological and perioperative care, outcomes for high-risk patients have not shown significant improvement, prompting interest in temporary mechanical circulatory support (tMCS) as a proactive strategy. This Expert Consensus Document from the European Association for Cardio-Thoracic Surgery (EACTS) presents the first dedicated guidance on the pre-emptive use of tMCS in high-risk adult cardiac surgical patients. Developed by a multidisciplinary task force, it emphasises structured risk stratification, early initiation, and individualised device management informed by interdisciplinary Heart Team discussions. The document proposes clinical pathways for patient selection, defines criteria for tMCS initiation, and provides practical algorithms for various scenarios, including advanced heart failure, cardiogenic shock, and post-cardiotomy LCOS. It reviews the current evidence on available tMCS devices, such as intra-aortic balloon pumps, microaxial flow pumps, veno-arterial extracorporeal life support and hybrid strategies, and addresses perioperative care, intensive care unit protocols, ethical considerations, as well as informed consent and support withdrawal. Despite promising results, substantial knowledge gaps remain, including long-term outcome data, device selection criteria, and cost-effectiveness analyses. This consensus aims to support clinical decision-making, standardise practice, and stimulate research to improve outcomes in a growing population of high-risk surgical patients.